Washington Report Articles
The U.S. Food and Drug Administration and the European Medicines Agency has launched a bilateral Good Clinical Practices Initiative, designed to ensure that clinical trials submitted in drug marketing applications in the United States and Europe are conducted uniformly, appropriately and ethically.
In addition to the new health insurance reform law, states are looking into some of the most important issues that affect patients’ access to care.
On March 23, 2010, President Barack Obama signed into law the new healthcare reform legislation titled the Affordable Health Care for America Act.
The healthcare reform bill meant to increase benefits for the uninsured and underinsured still leaves issues for patients with chronic and rare diseases.
The Alliance for Plasma Therapies received its 501(c)(3) nonprofit status from the Internal Revenue Service inApril 2009.
In 2010, monthly premiums for Medicare beneficiaries who are enrolled in Part D stand-alone prescription drug plans will rise 11 percent on average.